PanGen Biotech Inc. (KOSDAQ:222110)

Ligand Pharmaceuticals Revenue

PanGen Biotech had revenue of 3.44B KRW in the quarter ending March 31, 2025, a decrease of -0.96%. This brings the company's revenue in the last twelve months to 14.64B, up 45.57% year-over-year. In the year 2024, PanGen Biotech had annual revenue of 14.67B with 100.58% growth.

• Revenue (ttm): 14.64B
• Revenue Growth: +45.57%
• P/S Ratio: 5.73
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 83.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	14.67B	7.36B	100.58%
Dec 31, 2023	7.32B	814.47M	12.53%
Dec 31, 2022	6.50B	-1.43B	-18.08%
Dec 31, 2021	7.94B	1.74B	28.18%
Dec 31, 2020	6.19B	3.31B	114.87%